Angela Ragazzini

991 total citations
17 papers, 490 citations indexed

About

Angela Ragazzini is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Hepatology. According to data from OpenAlex, Angela Ragazzini has authored 17 papers receiving a total of 490 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 5 papers in Pulmonary and Respiratory Medicine and 4 papers in Hepatology. Recurrent topics in Angela Ragazzini's work include Colorectal Cancer Treatments and Studies (10 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers) and Cancer Treatment and Pharmacology (4 papers). Angela Ragazzini is often cited by papers focused on Colorectal Cancer Treatments and Studies (10 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers) and Cancer Treatment and Pharmacology (4 papers). Angela Ragazzini collaborates with scholars based in Italy and United States. Angela Ragazzini's co-authors include Alessandro Passardi, Giovanni Luca Frassineti, Dino Amadori, Paola Ulivi, Wainer Zoli, Elisa Chiadini, Giulia Gallerani, Francesco� Fabbri, Silvia Carloni and Pietro Fici and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

In The Last Decade

Angela Ragazzini

17 papers receiving 481 citations

Peers

Angela Ragazzini

ONCOL

PRM

G. Pasquini Italy

Seonggyu Byeon South Korea

Won Kyung Cho South Korea

Gerry Gin Wai Kwok China

Wang‐Zhong Li China

Marco Russano Italy

Emine Acar Türkiye

Xianhe Xie China

Praveen Sridhar United States

Guanghai Dai China

G. Pasquini Italy

Angela Ragazzini

306 ×0.9

ONCOL

166 ×1.0

201 ×1.6

PRM

210 ×2.4

34 ×0.4

Citations per year, relative to Angela Ragazzini Angela Ragazzini (= 1×) peers G. Pasquini

Countries citing papers authored by Angela Ragazzini

Since Specialization

Citations

This map shows the geographic impact of Angela Ragazzini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angela Ragazzini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angela Ragazzini more than expected).

Fields of papers citing papers by Angela Ragazzini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angela Ragazzini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angela Ragazzini. The network helps show where Angela Ragazzini may publish in the future.

Co-authorship network of co-authors of Angela Ragazzini

This figure shows the co-authorship network connecting the top 25 collaborators of Angela Ragazzini. A scholar is included among the top collaborators of Angela Ragazzini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angela Ragazzini. Angela Ragazzini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Fabbri, Francesca, Patrizia Serra, Bernadette Vertogen, et al.. (2020). How Many Cancer Clinical Trials Can a Clinical Research Coordinator Manage? The Clinical Research Coordinator Workload Assessment Tool. JCO Oncology Practice. 17(1). e68–e76. 7 indexed citations

Barone, Domenico, Emanuela Scarpi, Devil Oboldi, et al.. (2018). Dynamic contrast-enhanced ultrasonography (D-CEUS) for the early prediction of bevacizumab efficacy in patients with metastatic colorectal cancer. European Radiology. 28(7). 2969–2978. 19 indexed citations

Marisi, Giorgia, Emanuela Scarpi, Alessandro Passardi, et al.. (2017). Circulating VEGF and eNOS variations as predictors of outcome in metastatic colorectal cancer patients receiving bevacizumab. Scientific Reports. 7(1). 1293–1293. 24 indexed citations

Passardi, Alessandro, Emanuela Scarpi, Fabio Gelsomino, et al.. (2017). Impact of second-line cetuximab-containing therapy in patients with KRAS wild-type metastatic colorectal cancer: results from the ITACa randomized clinical trial. Scientific Reports. 7(1). 10426–10426. 9 indexed citations

Marisi, Giorgia, Emanuela Scarpi, Alessandro Passardi, et al.. (2016). Prognostic and predictive role of circulating eNOS and EPHB4 in metastatic colorectal cancer patients receiving bevacizumab.. Journal of Clinical Oncology. 34(15_suppl). e23083–e23083. 1 indexed citations

Passardi, Alessandro, Oriana Nanni, Davide Tassinari, et al.. (2015). Effectiveness of bevacizumab added to standard chemotherapy in metastatic colorectal cancer: final results for first-line treatment from the ITACa randomized clinical trial. Annals of Oncology. 26(6). 1201–1207. 121 indexed citations

Delmonte, Angelo, Marita Mariotti, Emanuela Scarpi, et al.. (2015). Venous thromboembolic events in advanced adenocarcinoma of the lung: impact on prognosis according to platinum therapies and presence of driver mutations. Annals of Oncology. 26. vi83–vi83. 2 indexed citations

Delmonte, Angelo, Marita Mariotti, Emanuela Scarpi, et al.. (2015). Adenocarcinoma of the lung and venous thromboembolic events: a monoinstitutional, retrospective evaluation.. Journal of Clinical Oncology. 33(15_suppl). e19149–e19149. 2 indexed citations

Farolfi, Alberto, Elisa Carretta, Angela Ragazzini, et al.. (2014). Does the time between CT scan and chemotherapy increase the risk of acute adverse reactions to iodinated contrast media in cancer patients?. BMC Cancer. 14(1). 792–792. 3 indexed citations

10.

Casadei‐Gardini, Andrea, Laura Capelli, Paola Ulivi, et al.. (2014). KRAS, BRAF and PIK3CA Status in Squamous Cell Anal Carcinoma (SCAC). PLoS ONE. 9(3). e92071–e92071. 40 indexed citations

11.

Ulivi, Paola, Angelo Delmonte, Elisa Chiadini, et al.. (2014). Gene Mutation Analysis in EGFR Wild Type NSCLC Responsive to Erlotinib: Are There Features to Guide Patient Selection?. International Journal of Molecular Sciences. 16(1). 747–757. 22 indexed citations

12.

Farolfi, Alberto, Angela Ragazzini, Elisa Carretta, et al.. (2014). Taxanes as a Risk Factor for Acute Adverse Reactions to Iodinated Contrast Media in Cancer Patients. The Oncologist. 19(8). 823–828. 8 indexed citations

13.

Fabbri, Francesco�, Silvia Carloni, Wainer Zoli, et al.. (2013). Detection and recovery of circulating colon cancer cells using a dielectrophoresis-based device: KRAS mutation status in pure CTCs. Cancer Letters. 335(1). 225–231. 183 indexed citations

14.

Casadei‐Gardini, Andrea, Federica Pieri, Pietro Fusaroli, et al.. (2013). Hemangioblastoma of the Gastrointestinal Tract. International Journal of Surgical Pathology. 21(2). 192–196. 4 indexed citations

15.

Passardi, Alessandro, Emanuela Scarpi, Luigi Cavanna, et al.. (2013). Effectiveness of bevacizumab added to gold standard chemotherapy in metastatic colorectal cancer (mCRC): Final results from the Itaca randomized clinical trial.. Journal of Clinical Oncology. 31(15_suppl). 3517–3517. 7 indexed citations

16.

Ulivi, Paola, Laura Capelli, Martina Valgiusti, et al.. (2012). Predictive role of multiple gene alterations in response to cetuximab in metastatic colorectal cancer: A single center study. Journal of Translational Medicine. 10(1). 87–87. 36 indexed citations

17.

Passardi, Alessandro, Paola Ulivi, Martina Valgiusti, et al.. (2011). The role of KRAS, BRAF, and PI3K mutations as markers of resistance to cetuximab in metastatic colorectal cancer.. Journal of Clinical Oncology. 29(15_suppl). 3603–3603. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact